The life sciences industry is facing serious challenges. Stakeholder collaborations, new
digital technologies and therapeutic approaches have had a dramatic impact on drug
and device development. Heightened global competition, tougher regulatory standards, outsourcing strategies and continued cost pressures are the driving forces for efficient innovation. The digital transformation of life sciences and increased consumer/patient demands are changing the industry. Tech giants are diversifying into health care, while a new generation of startups is entering the market. With the size of investments in life sciences, scaling the business internationally is imperative.
Globe & Seas was involved in a number of business expansion projects in pharmaceuticals and biotech in China, including partner search, business and financial plan reviews.
